G Life Quantum is pioneering its own proprietary Quantum BioModulation Therapy (QBMT), a hybrid disruptive technology, building on the principles of biomodulation (PBM). It applies non-thermal light with the aim to induce an epigenetic response to treat and manage a range of pathologies.

Quantum BioModulation Therapy is minimally invasive and represents a highly targeted/localized quantum biophysical approach inside the body using specific photonic dosing to alter the expression of genes implicated in the pathological process; particularly governing inflammation, cellular metabolism and cell death.

The interplay between energy, matter, and information can be triggered through a process called Quantum BioModulation (QBM).

During QBM, photons penetrate the tissue and interact with proteins involved in mitochondrial function, such as components of the cytochrome c system.

Cytochrome c plays a key role in the mitochondrial electron transport chain, which is essential for cellular energy production. The effects of QBM on cellular metabolism should be scribed in accordance with the available experimental evidence.

However, many other proteins, including NADPH oxidase and hemoglobin, can also interact with photons.

Photonic stimulation also produces free NO and modulates ROS. NO is a powerful vasodilator and an important cellular signaling molecule involved in many physiological processes. ROS have been shown to affect many important physiological signaling pathways including the inflammatory response. Together, increased NO and improved ROS levels provide an environment for faster signaling, resulting in decreased inflammation.